Loss of Response of Adalimumab Biosimilar vs Adalimumab Original, in Inflammatory Bowel Disease.
Conditions: Crohn Disease; Ulcerative Colitis Interventions: Drug: Amgevita 40Mg Solution for Injection; Drug: HUMIRA 40Mg Solution for Injection Sponsor: Fundación Pública Andaluza para la gestión de la Investigación en Sevilla Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials